Home  /  RCPA Anatomical Pathology  /  Study notes  /  Wound Healing and Fibrosis: Primary vs Secondary Intention, Granulation Tissue, Abnormal Scarring, and Organ Fibrosis Grading

Wound Healing and Fibrosis: Primary vs Secondary Intention, Granulation Tissue, Abnormal Scarring, and Organ Fibrosis Grading

RCPA Anatomical Pathology LO RCPA_AP_DS11_1_e 1,867 words
Free preview. This study note maps to learning objective RCPA_AP_DS11_1_e in the RCPA Anatomical Pathology curriculum. Inside Primex you get the full set of RCPA Anatomical Pathology notes, AI-graded SAQs and written-paper practice, voice viva with an AI examiner, exam-style MCQs, and a curriculum tracker that ticks off every learning objective as you go. For exam format, timeline and failure-mode commentary, see the RCPA Anatomical Pathology 2026 Study Guide.

Overview

Tissue repair following injury proceeds through overlapping phases of inflammation, cellular proliferation, and extracellular matrix (ECM) remodelling. Outcome depends on the nature, extent, and location of injury, and on the regenerative capacity of the affected tissue. Where regeneration is insufficient, repair by scar formation (fibrosis) occurs. When fibrosis develops within an inflammatory exudate (e.g., pleural or peritoneal space), the process is termed organisation. Understanding the mechanisms and pathological deviations of wound healing is essential for recognising clinical complications and interpreting histological findings in surgical pathology specimens.


Phases of Wound Healing

All wound healing proceeds through three interconnected phases:

Phase Timing Key Events
Inflammation Hours to days Coagulation, clot formation, neutrophil then macrophage recruitment, phagocytosis of debris
Proliferative (granulation) Days to weeks Angiogenesis, fibroblast migration and proliferation, collagen synthesis, re-epithelialisation
Remodelling (maturation) Weeks to months Collagen cross-linking and increased fibre size, vascular regression, increased tensile strength

Primary vs Secondary Intention Healing

Healing by Primary Intention (First Intention)

Healing by Secondary Intention (Second Intention)

Feature Primary Intention Secondary Intention
Tissue defect Minimal Large
Fibrin clot Small Large
Inflammatory response Mild Intense (more necrotic debris/exudate to clear)
Granulation tissue Minimal Abundant
Wound contraction Absent/minimal Prominent and essential
Scar size Small, fine Large, broad
Re-epithelialisation Rapid, minimal migration Extensive migration required

Granulation Tissue: Components and Histology

Granulation tissue is the hallmark of repair and must be clearly distinguished from a granuloma (a discrete aggregate of epithelioid histiocytes, a feature of specific chronic inflammatory disorders, with minimal vascularity).

Histological Components

Component Role
Thin-walled capillary loops (neovascularisation) Oxygen and nutrient delivery; vessels are leaky, contributing to oedema of new granulation tissue
Fibroblasts Proliferate; synthesise collagen and ECM components
Myofibroblasts Wound contraction; express $\alpha$-smooth muscle actin
Alternatively activated (M2) macrophages Clear debris; secrete TGF-$\beta$, VEGF, and other fibrogenic/angiogenic cytokines
Loose ECM (proteoglycans, fibronectin) Scaffold for cell migration
Variable inflammatory infiltrate Mast cells, lymphocytes, predominantly mononuclear cells in established granulation tissue

Key Molecular Mediators

As the scar matures, fibroblasts assume a more synthetic phenotype, ECM deposition increases, and progressive vascular regression transforms vascularised granulation tissue into a pale, largely avascular scar. Tensile strength results from excess collagen synthesis over degradation and cross-linking of collagen fibres during the first 2 months. Carefully sutured wounds reach approximately 70% of normal skin strength due to suture placement; wound strength reaches approximately 70-80% of normal by 3 months and does not substantially improve beyond that point.


Abnormal Scarring: Keloid vs Hypertrophic Scar

Both represent excessive collagen deposition following dermal injury.

Feature Hypertrophic Scar Keloid
Definition Raised scar confined within original wound boundaries Scar tissue extending beyond original wound margins
Regression Regresses spontaneously over months Does not regress; may continue to enlarge
Typical cause Thermal or deep dermal traumatic injury Surgery, burn, or even minor wound
Genetic predisposition Less pronounced Strong individual predisposition; more prevalent in individuals of African descent
Recurrence after excision Lower High; excision alone insufficient
Histology Abundant myofibroblasts; organised collagen Thick, glassy, haphazardly arranged ("keloidal") collagen bundles in dermis
Location predilection Any deep dermal wound Ear lobes, sternum, shoulders, upper back

Related Abnormalities


Organ Fibrosis: Mechanisms and Grading Schemes

General Pathogenesis

Fibrosis in parenchymal organs shares fundamental mechanisms with dermal scar formation. Persistent or repeated injury leads to chronic inflammation, sustained TGF-$\beta$ pathway activation, and progressive ECM deposition replacing functional parenchyma, often with substantial organ dysfunction or failure. Key fibrogenic effector cells vary by organ:

Organ Key Fibrogenic Effector Cell
Liver Hepatic stellate cell (Ito cell) - activated by chronic injury
Kidney Interstitial fibroblast / pericyte
Lung Fibroblast / myofibroblast

Important fibrotic disorders include: liver cirrhosis, systemic sclerosis (scleroderma), idiopathic pulmonary fibrosis (IPF), pneumoconioses, drug- and radiation-induced pulmonary fibrosis, end-stage kidney disease, and constrictive pericarditis.

Hepatic Fibrosis Grading

Multiple validated staging systems exist. Grading refers to degree of necroinflammatory activity; staging refers to degree of fibrosis - both must be reported on liver biopsy.

METAVIR (primarily chronic viral hepatitis):

Stage Description
F0 No fibrosis
F1 Portal fibrosis without septa
F2 Portal fibrosis with few septa
F3 Numerous septa without cirrhosis (bridging fibrosis)
F4 Cirrhosis

Ishak (0-6; finer granularity at bridging/cirrhosis transition):

Score Description
0 No fibrosis
1-2 Fibrous expansion of some/most portal areas
3-4 Bridging fibrosis (portal-portal or portal-central)
5 Marked bridging with occasional nodules
6 Cirrhosis

Specific systems also exist for NAFLD/NASH (NASH CRN/Brunt system) and primary biliary cholangitis. Across systems, advanced fibrosis is defined as bridging fibrosis (stage 3) progressing to cirrhosis (stage 4/6), characterised by distortion of normal architecture with regenerative nodule formation, decreased hepatocellular mass, altered blood flow, activation of hepatic stellate cells, and increased collagen/ECM deposition. Decompensated cirrhosis is defined by ascites, hepatic encephalopathy, or variceal bleeding.

Pulmonary Fibrosis Grading

Pulmonary fibrosis (IPF, pneumoconioses, drug-induced, radiation-induced) is assessed histologically on surgical lung biopsy, with HRCT correlation. Histological pattern carries independent prognostic weight.

The usual interstitial pneumonia (UIP) pattern (recognised by ATS/ERS/JRS/ALAT guidelines and WHO classification) is most important: - Temporal and spatial heterogeneity - Subpleural, basal-predominant distribution - Honeycombing with or without peripheral traction bronchiectasis - Fibroblastic foci at the advancing edge of fibrosis (marker of active disease progression; high density predicts more rapid functional decline and shorter survival in IPF)

Other histological patterns: NSIP, DIP, RB-ILD, organising pneumonia - each with distinct prognostic implications. Semi-quantitative biopsy scoring assesses proportion of affected parenchyma, honeycombing, and fibroblastic focus density.

Renal Fibrosis Grading

Interstitial fibrosis and tubular atrophy (IFTA) represent the final common pathway of chronic kidney injury and are the strongest histological predictors of progression to end-stage renal disease.

Banff Classification (transplant biopsies) scores interstitial fibrosis (ci) and tubular atrophy (ct) separately on a 0-3 scale:

Score Interstitial Fibrosis (ci) Tubular Atrophy (ct)
0 $\leq 5\%$ of cortex $\leq 5\%$ of tubules
1 6-25% 6-25%
2 26-50% 26-50%
3 $>50\%$ $>50\%$

For native renal biopsies, IFTA is typically reported as percentage of cortical area: mild ($<25\%$), moderate (25-50%), or severe ($>50\%$). IFTA $>25\%$ is associated with significantly accelerated progression to end-stage renal failure.


Factors Modifying Wound Healing

Factor Effect
Infection Most important cause of delayed healing; prolongs inflammation, increases local tissue injury
Diabetes mellitus Impaired angiogenesis, neuropathy, immune dysfunction, poor collagen synthesis
Malnutrition (protein or vitamin C deficiency) Inhibits collagen synthesis, retards healing
Glucocorticoids Anti-inflammatory; inhibit TGF-$\beta$ production, reduce fibrosis, weaken scar
Ischaemia/vascular insufficiency Reduces oxygen and nutrient delivery
Obesity Increases risk of wound dehiscence
Wound dehiscence Internal or external wound reopening; precipitated by obesity, malnutrition, infection, vomiting, coughing

Diagnostic Pitfalls


Clinical Correlates and Prognosis

Primex

Practice this topic in the app

Work through MCQs on this exact LO, run written or viva practice mapped to RCPA_AP_DS11_1_e, or ask PRIMEX a clinical question framed for RCPA Anatomical Pathology. Your free trial covers all 20 specialist exams.

Start 7-day free trial
Start free trial